Showing results (61-70 of 1,393) with videos related to
Sort By:
Pageof 140
JCO Precision Oncology|February 21, 2022
Utility of Perioperative Measurement of Cell-Free DNA and Circulating Tumor DNA in Informing the Prognosis of GI Cancers: A Systematic ReviewPhillip J Hsu, Khushboo Singh, Ankit Dhiman, et al.JCO Precision Oncology|February 1, 2022
Comparative Analysis of Durable Responses on Immune Checkpoint Inhibitors Versus Other Systemic Therapies: A Pooled Analysis of Phase III TrialsElvire Pons-Tostivint, Aurélien Latouche, Pauline Vaflard, et al.JCO Precision Oncology|February 1, 2022
Direct Ex Vivo Observation of Homologous Recombination Defect Reversal After DNA-Damaging Chemotherapy in Patients With Metastatic Breast CancerTitia G Meijer, Nicole S Verkaik, Carolien H M van Deurzen, et al.JCO Precision Oncology|February 1, 2022
Orthogonal Comparison of Four Plasma NGS Tests With Tumor Suggests Technical Factors are a Major Source of Assay DiscordanceDaniel Stetson, Ambar Ahmed, Xing Xu, et al.JCO Precision Oncology|February 1, 2022
Experiences of a Multidisciplinary Genomic Tumor Board Interpreting Risk for Underlying Germline Variants in Tumor-Only Sequencing ResultsKristen P Fishler, Erin H Breese, Lauren Walters-Sen, et al.JCO Precision Oncology|February 1, 2022
Parents', Health Care Professionals', and Scientists' Experiences of a Precision Medicine Pilot Trial for Patients With High-Risk Childhood Cancer: A Qualitative StudyJanine Vetsch, Claire E Wakefield, Emily Duve, et al.JCO Precision Oncology|February 1, 2022
Predictive and Prognostic Properties of Human Equilibrative Nucleoside Transporter 1 Expression in Gemcitabine-Treated Pancreatobiliary Cancer: A Meta-AnalysisLarissa J Vos, Dimas Yusuf, Arthur Lui, et al.JCO Precision Oncology|January 27, 2022
Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With NeuroblastomaIedan R N Verly, Yvette A H Matser, René Leen, et al.JCO Precision Oncology|January 27, 2022
Improved Gene Fusion Detection in Childhood Cancer Diagnostics Using RNA SequencingJayne Y Hehir-Kwa, Marco J Koudijs, Eugene T P Verwiel, et al.JCO Precision Oncology|February 2, 2022
Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future ChallengesJocelyn Y Hsu, Nathan D Seligson, John L Hays, et al.Pageof 140